Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy...
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study
About this item
Full title
Author / Creator
Nagane, Motoo , Ichimura, Koichi , Onuki, Ritsuko , Narushima, Daichi , Honda-Kitahara, Mai , Satomi, Kaishi , Tomiyama, Arata , Arai, Yasuhito , Shibata, Tatsuhiro , Narita, Yoshitaka , Uzuka, Takeo , Nakamura, Hideo , Nakada, Mitsutoshi , Arakawa, Yoshiki , Ohnishi, Takanori , Mukasa, Akitake , Tanaka, Shota , Wakabayashi, Toshihiko , Aoki, Tomokazu , Aoki, Shigeki , Shibui, Soichiro , Matsutani, Masao , Ishizawa, Keisuke , Yokoo, Hideaki , Suzuki, Hiroyoshi , Morita, Satoshi , Kato, Mamoru and Nishikawa, Ryo
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
We evaluated the efficacy and safety of bevacizumab beyond progression (BBP) in Japanese patients with newly diagnosed glioblastoma and explored predictors of response to bevacizumab. This phase II study evaluated a protocol-defined primary therapy by radiotherapy with concurrent and adjuvant temozolomide plus bevacizumab, followed by bevacizumab m...
Alternative Titles
Full title
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study
Authors, Artists and Contributors
Author / Creator
Ichimura, Koichi
Onuki, Ritsuko
Narushima, Daichi
Honda-Kitahara, Mai
Satomi, Kaishi
Tomiyama, Arata
Arai, Yasuhito
Shibata, Tatsuhiro
Narita, Yoshitaka
Uzuka, Takeo
Nakamura, Hideo
Nakada, Mitsutoshi
Arakawa, Yoshiki
Ohnishi, Takanori
Mukasa, Akitake
Tanaka, Shota
Wakabayashi, Toshihiko
Aoki, Tomokazu
Aoki, Shigeki
Shibui, Soichiro
Matsutani, Masao
Ishizawa, Keisuke
Yokoo, Hideaki
Suzuki, Hiroyoshi
Morita, Satoshi
Kato, Mamoru
Nishikawa, Ryo
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9688169
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9688169
Other Identifiers
ISSN
2072-6694
E-ISSN
2072-6694
DOI
10.3390/cancers14225522
